NDA 6811, held by Panray. Aminosalicylic Acid, Aminosalicylate Sodium.
As of Nov 14, 2026, NDA 6811 (Parasal, Parasal Sodium), held by Panray, was not approved, with 0 approved supplements and 0 published complete response letters.
| Parasal500MG · tablet;oral | Aminosalicylic Acid | Discontinued |
| Parasal1GM · tablet;oral | Aminosalicylic Acid | Discontinued |
| Parasal Sodium500MG · tablet;oral | Aminosalicylate Sodium | Discontinued |
| Parasal Sodium1GM · tablet;oral | Aminosalicylate Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
